Natasha Atanaskova Mesinkovska

Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial

Brett King, Xingqi Zhang, Walter Gubelin Harcha et al. · The Lancet · 2023 · 220 citations · Full text

Phase 2B–3, Pharmacology, Clinical Dermatology +5

A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity

Andy Goren, Sergio Vañó‐Galván, Carlos Gustavo Wambier et al. · Journal of Cosmetic Dermatology · 2020 · 197 citations · Full text

Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study

Brett King, Justin Ko, Seth Forman et al. · Journal of the American Academy of Dermatology · 2021 · 111 citations · Full text

The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials

Kathleen W. Wyrwich, Helen Kitchen, S.L. Knight et al. · British Journal of Dermatology · 2020 · 94 citations · Full text

The Effect of Patch Testing on Surgical Practices and Outcomes in Orthopedic Patients With Metal Implants

Natasha Atanaskova Mesinkovska, Alejandra Téllez, Luciana Molina et al. · Archives of Dermatology · 2012 · 93 citations